Jonathan Clements, a longtime personal finance columnist for The Wall Street Journal, has a lot of savings. He’s not mad that a fatal illness will keep him from spending it.
A reader is fuming after a friend lied about her efforts to get a wig made for a sick child, and thinks her other friends should know about the deception.
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.